10x Genomics' share price is down nearly 15% today and >70% year-to-date. The company offers innovative products for biological analysis but faces heavy losses and declining revenues of key products.
July 11 (Reuters) - A federal judge in Delaware said on Monday that 10x Genomics (TXG.O), opens new tab and Harvard University must face antitrust counterclaims over their licensing practices in two ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-second-quarter-2025-financial-results-302524722.html SOURCE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback